Please login to the form below
11
Revenue 2017AstraZeneca
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca.
HTA guidance from NICE, the SMC and the AWMSG
Specifically, NICE’s recommendation is. 11 Nov 2022. The Institute of Cancer Research (ICR) has called for further discussions between AstraZeneca (AZ), NHS England and the National Institute for Health and
AZ and MSD launch ‘Never Miss’ for prostate cancer awareness
A new prostate cancer awareness campaign titled‘Never Miss’ has been launched by AstraZeneca (AZ) in partnership with MSD – known as Merck &Co in the US and Canada.
Cancer Research Horizons and the Karolinska Institutet announce five-year strategic partnership
Through the partnership, Karolinska Institutet researchers will also be able to access the Cancer Research Horizons AstraZeneca Antibody Alliance Lab to use AstraZeneca’s phage display technology and associated technologies to
AstraZeneca to acquire Neogene Therapeutics in $320m deal
AstraZeneca (AZ) has announced it will acquire Neogene Therapeutics, a clinical-stage biotech focused on the development of next-generation T-cell receptor therapies (TCR-T) for targeting solid tumours, in
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Senior Account Manager, Patient/ Medical Communications agency, ...
-
Highly competitive salary
- Lilly’s donanemab shows promise in early symptomatic Alzheimer's comparator study
- World-first trial launches in UK to assess stem cell transplants as first-line MS treatment
- The role of digital health technology tools in supporting medical adherence
- Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations
- GSK’s Jemperli shows promise in phase 3 endometrial cancer trial
- MHRA approves LEO Pharma’s Adtralza for adolescent patients with atopic dermatitis
- How to Increase Engagement During Virtual Events
- What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
- Pfizer’s RSV vaccine candidate accepted for FDA priority review for use in older adults
- Summit Therapeutics partners with Akeso in deal worth $5bn
- Enzyvant and Altavant announce merger to accelerate rare disease therapies
- NHS Digital Health Check begins trial to ease pressure on services
- Locus Biosciences announces first patient treated in urinary tract infection trial
- World-first trial launches in UK to assess stem cell transplants as first-line MS treatment
- Lilly’s donanemab shows promise in early symptomatic Alzheimer's comparator study
- Concerns about data security are building a strong case for clinical mobility in EMEA
- AstraZeneca to acquire Neogene Therapeutics in $320m deal
- Bristol Myers Squibb’s Opdivo recommended by NICE for rare gastroesophageal cancers
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Infographic: Therapy Watch Hyperlipidaemia
- Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
- Article: The rise of the healthcare influencer
- In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
- Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
- ...
